Siemens Healthineers AG: EPS $0.782 vs $0.76 expected; revenue $7.69B vs $7.69B
Key Facts
Q4 FY2026 results
| Metric | Actual | Estimate | Surprise | Year ago |
|---|---|---|---|---|
| EPS (USD) | 0.782 | 0.760 | +2.9% | 0.617 |
| Revenue (USD bn) | 7.690 | 7.690 | — | 10.380 |
Recent reports: actual vs estimate
| Reported | Period | EPS (USD) | Estimate | Surprise | Revenue (USD bn) | Estimate | Surprise |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Q4 FY2026 | 0.7820 | 0.7600 | +2.9% | 7.69 | 7.69 | — |
| Jul 31, 2026 | Q3 FY2026 | 0.7990 | 0.6040 | +32.3% | 6.58 | 6.47 | +1.7% |
| May 7, 2026 | Q2 FY2026 | 0.6120 | 0.5830 | +5.0% | 6.56 | 6.85 | −4.2% |
| Feb 5, 2026 | Q1 FY2026 | 0.5760 | 0.5240 | +9.9% | 6.34 | 6.22 | +2.0% |
| Nov 5, 2025 | Q4 FY2025 | 0.6170 | 0.8070 | −23.5% | 10.38 | — | — |
| Jul 30, 2025 | Q3 FY2025 | 0.5770 | 0.6250 | −7.7% | 6.67 | — | — |
| May 5, 2025 | Q2 FY2025 | 0.5150 | 0.6130 | −16.0% | 6.48 | 6.60 | −1.9% |
| Feb 6, 2025 | Q1 FY2025 | 0.4349 | 0.4874 | −10.8% | 5.68 | 5.54 | +2.4% |
Source: Figures from the EL7 database. Estimates are the analyst consensus carried by our data vendor (FMP), not official figures. Figures are in USD as carried for this US-traded line; the company reports in another currency.
Siemens Healthineers AG results: EPS $0.782 vs $0.76 expected; revenue $7.69B vs $7.69B. The results cover the company's Q4 FY2026. EPS came in above analysts' estimate by 2.9%; revenue in line with the estimate. Figures are in USD as carried for this US-traded line; the company reports in EUR.
Revenue was down 25.9% from $10.38 billion a year earlier (Q4 FY2025). EPS was up 26.7% from $0.617 a year earlier. On its record, EPS topped analysts' estimates in 3 of 7 earlier comparable reports.
What the results mean
Declining revenue puts the performance of individual businesses in focus. Imaging and Advanced Therapies supply medical technologies for healthcare facilities, while Diagnostics includes laboratory solutions and services, and Varian combines treatment technologies with clinical support and digital tools.
The company's role also extends to organizing workflows and managing diagnostic and treatment processes. Its business drivers therefore include how effectively these solutions serve healthcare organizations in operating laboratories and coordinating patient care, alongside equipment sales.
What to watch on the earnings call: what management says about demand, margins and spending plans for the period ahead.
For the full analysis of Siemens Healthineers AG stock — valuation, scores and financial statements — see the stock page linked with this story.